Tissue Transglutaminase Expression Associates With Progression of Multiple Sclerosis

OBJECTIVE: The clinical course of multiple sclerosis (MS) is variable and largely unpredictable pointing to an urgent need for markers to monitor disease activity and progression. Recent evidence revealed that tissue transglutaminase (TG2) is altered in patient-derived monocytes. We hypothesize that...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurol Neuroimmunol Neuroinflamm
Main Authors: Sestito, Claudia, Leurs, Cyra E., Steenwijk, Martijn D., Brevé, John J.P., Twisk, Jos W.R., Wilhelmus, Micha M.M., Drukarch, Benjamin, Teunissen, Charlotte E., van Dam, Anne-Marie, Killestein, Joep
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8105890/
https://ncbi.nlm.nih.gov/pubmed/33906937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000998
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados